Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:0
|
作者
Ming Shi
机构
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM:To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization(TACE)procedure in unresectable hepatocellular carcinoma(HCC). METHODS:One thousand and five hundred and sixtynine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied.Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS:The median overall survival time and 1-, 5-,10-year survival rates were 10.37 mo,47%,10%, and 7%,respectively.A Cox proportional hazard model showed that 8 pretreatment factors of regional lymphnodes metastasis,Child-Pugh class,macrovascular invasion,greatest dimension,α-fetoprotein(AFP), Hepatitis virus B,tumor capsule,and nodules were independent prognostic factors.Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION:Tumor status,hepatic function reserve,AFP,and hepatitis virus B status were independent prognostic factors for unresectable HCC.Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [31] Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
    Zhong, Bin-Yan
    Jin, Zhi-Cheng
    Chen, Jian-Jian
    Zhu, Hai-Dong
    Zhu, Xiao-Li
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (02) : 480 - 489
  • [32] Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
    Kim, Jihye
    Sinn, Dong-Hyun
    Choi, Moon Seok
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    PLOS ONE, 2019, 14 (03):
  • [33] Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma
    Kishi, Yoji
    Saiura, Akio
    Yamamoto, Junji
    Koga, Rintaro
    Seki, Makoto
    Morimura, Ryo
    Yoshioka, Ryuji
    Kokudo, Norihiro
    Yamaguchi, Toshiharu
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2295 - 2299
  • [34] Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
    Guo, Chengxiang
    Du, Weiran
    Chen, Yiwen
    Xiao, Wenbo
    Sun, Ke
    Shen, Yan
    Zhang, Min
    Wu, Jian
    Gao, Shunliang
    Yu, Jun
    Que, Risheng
    Xue, Xing
    Bai, Xueli
    Liang, Tingbo
    CANCER MEDICINE, 2025, 14 (03):
  • [35] Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Zhao, Chang
    Fan, Liwei
    Qi, Feng
    Ou, Shengqiu
    Yu, Lei
    Yi, Xiaoyu
    Ni, Bingqiang
    Zheng, Zhiyong
    Lu, Jianxun
    Zhang, Chengwen
    Cheng, Changsheng
    Lu, Xiong
    Cheng, Lin
    Hu, Tianlian
    Ma, Yilong
    ANTI-CANCER DRUGS, 2016, 27 (07) : 689 - 694
  • [36] Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study
    Guo, Wenbo
    Chen, Song
    Wu, Zhiqiang
    Zhuang, Wenquan
    Yang, Jianyong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [37] Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
    Ma, Jun
    Bo, Zhiyuan
    Zhao, Zhengxiao
    Yang, Jinhuan
    Yang, Yan
    Li, Haoqi
    Yang, Yi
    Wang, Jingxian
    Su, Qing
    Wang, Juejin
    Chen, Kaiyu
    Yu, Zhengping
    Wang, Yi
    Chen, Gang
    CANCERS, 2023, 15 (03)
  • [38] Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study
    Yue Han
    Guang Cao
    Bin Sun
    Jian Wang
    Dong Yan
    Haifeng Xu
    Qinsheng Shi
    Zechuan Liu
    Weihua Zhi
    Liang Xu
    Bojun Liu
    Yinghua Zou
    BMC Gastroenterology, 21
  • [39] Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study
    Turpin, Anthony
    de Baere, Thierry
    Heurgue, Alexandra
    Le Malicot, Karine
    Ollivier-Hourmand, Isabelle
    Lecomte, Thierry
    Perrier, Herve
    Vergniol, Julien
    Sefrioui, David
    Rinaldi, Yves
    Edeline, Julien
    Jouve, Jean-Louis
    Silvain, Christine
    Becouarn, Yves
    Dauvois, Barbara
    Baconnier, Mathieu
    Debette-Gratien, Maryline
    Deplanque, Gael
    Dharancy, Sebastien
    Lepage, Come
    Hebbar, Mohamed
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [40] Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
    Tao, Ziwen
    Ruan, Yuying
    Peng, Zhi
    Zhang, Kai
    Gao, Yanjing
    FRONTIERS IN ONCOLOGY, 2021, 11